Identification of aggregates in therapeutic formulations of recombinant full‐length factor VIII products by sedimentation velocity analytical ultracentrifugation

por Healey, J. F., Parker, E. T., Lollar, P.
Publicado 2018

Lack of recombinant factor VIII B-domain induces phospholipid vesicle aggregation: implications for the immunogenicity of factor VIII

por Grushin, K, Miller, J, Dalm, D, Parker, E T, Healey, J F, Lollar, P, Stoilova-McPhie, S
Publicado 2014